Skip to main content
Joel Blankson, MD, Infectious Disease, Baltimore, MD

JoelNee-LartleyBlanksonMD

Infectious Disease • Baltimore, MD

Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Blankson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blankson's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1995

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1998 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Publications & Presentations

PubMed

Journal Articles

  • Interferon-Α Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells  
    Joel Blankson, MD, mBio
  • CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in Humans  
    Justin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine
  • Highly Attenuated Infection with a Vpr-Deleted Molecular Clone of HIV-1  
    Peter A Anton, Jennifer A Fulcher, Otto O Yang, Joel N Blankson, The Journal of Infectious Diseases

Press Mentions

  • Breakthrough COVID Infections More Likely in People Living with HIV
    Breakthrough COVID Infections More Likely in People Living with HIVJune 9th, 2022
  • Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study Finds
    Antibodies from Covid Vaccines May Be Weaker Against Omicron, Study FindsApril 27th, 2022
  • Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against Omicron
    Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against OmicronApril 26th, 2022
  • Join now to see all

Grant Support

  • CD8+ T Cell Mediated Inhibition Of HIV-1 Replication In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2009–2012
  • Analysis Of HIV-1 In Mucosal Tissue In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2011
  • Characterization Of HIV Excape Mutants And T Cell Responses In Elite SuppressorsNational Institute Of Allergy And Infectious Diseases2007
  • Latent Virus And HIV-1 Specific Immunity In LtnpsNational Institute Of Allergy And Infectious Diseases2002–2006
  • Latency &Cell Distribution Of Virus In HIV1 InfectionNational Institute Of Allergy And Infectious Diseases1998–2000
  • Minority Predoctoral Fellowship ProgramNational Institute Of General Medical Sciences1991–1992

External Links

Dr. Joel Blankson, Dr. Joel Blankson, MD, Dr. J Blankson, Dr. Joel Nee-Lartley Blankson